These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 23944168)

  • 1. Sociodemographic predictors of cervical cancer screening in women with a medical disability.
    Martin S; Orlowski M; Ellison SA
    Soc Work Public Health; 2013; 28(6):583-90. PubMed ID: 23944168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast and cervical cancer screening disparities associated with disability severity.
    Horner-Johnson W; Dobbertin K; Andresen EM; Iezzoni LI
    Womens Health Issues; 2014; 24(1):e147-53. PubMed ID: 24439941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for cervical cancer: What are the determinants among adults with disabilities living in institutions? Findings from a National Survey in France.
    Bussière C; Le Vaillant M; Pelletier-Fleury N
    Health Policy; 2015 Jun; 119(6):794-801. PubMed ID: 25747512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilisation of cancer screening services by disabled women in Chile.
    Sakellariou D; Rotarou ES
    PLoS One; 2017; 12(5):e0176270. PubMed ID: 28459874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical and breast cancer-screening knowledge of women with developmental disabilities.
    Parish SL; Swaine JG; Luken K; Rose RA; Dababnah S
    Intellect Dev Disabil; 2012 Apr; 50(2):79-91. PubMed ID: 22642963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cervical and breast cancer screening among women with and without functional limitations--United States, 1994-1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(40):853-6. PubMed ID: 9790660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sociodemographic and lifestyle determinants of non-attendance for cervical cancer screening in Lithuania, 2006-2014.
    Petkeviciene J; Ivanauskiene R; Klumbiene J
    Public Health; 2018 Mar; 156():79-86. PubMed ID: 29408192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sociodemographic inequalities in sexual activity and cervical cancer screening: implications for the success of human papillomavirus vaccination.
    Drolet M; Boily MC; Greenaway C; Deeks SL; Blanchette C; Laprise JF; Brisson M
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):641-52. PubMed ID: 23549400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of Pap smear and its influencing factors among women with disabilities in Taiwan.
    Huang KH; Tsai WC; Kung PT
    Res Dev Disabil; 2012; 33(2):307-14. PubMed ID: 22100350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Cervical Cancer Screening in Title X-Funded Health Centers - United States, 2005-2015.
    Fowler CI; Saraiya M; Moskosky SB; Miller JW; Gable J; Mautone-Smith N
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):981-985. PubMed ID: 28934183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of human papilloma virus vaccine and cervical cancer screening among female health-care workers in Enugu, Southeast Nigeria.
    Ugwu EO; Obi SN; Ezechukwu PC; Okafor II; Ugwu AO
    Niger J Clin Pract; 2013; 16(2):249-52. PubMed ID: 23563471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening among women aged 18-30 years - United States, 2000-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jan; 61(51-52):1038-42. PubMed ID: 23282861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
    Howell LP; Gurusinghe S; Tabnak F; Sciortino S
    Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast and cervical cancer screening among Appalachian women.
    Hall HI; Uhler RJ; Coughlin SS; Miller DS
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):137-42. PubMed ID: 11815412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
    Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
    J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State-level differences in breast and cervical cancer screening by disability status: United States, 2008.
    Armour BS; Thierry JM; Wolf LA
    Womens Health Issues; 2009; 19(6):406-14. PubMed ID: 19879454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated with Self-Reported Cervical Cancer Screening Among Women Aged 18 Years and Older in the United States.
    Miles-Richardson S; Allen S; Claridy MD; Booker EA; Gerbi G
    J Community Health; 2017 Feb; 42(1):72-77. PubMed ID: 27496176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Absolute and Comparative Risk Perceptions on Cervical Cancer Screening and the Mediating Role of Cancer Worry.
    Zhao X; Nan X
    J Health Commun; 2016; 21(1):100-8. PubMed ID: 26312444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are cervical and breast cancer screening programmes equitable? The case of women with intellectual and developmental disabilities.
    Cobigo V; Ouellette-Kuntz H; Balogh R; Leung F; Lin E; Lunsky Y
    J Intellect Disabil Res; 2013 May; 57(5):478-88. PubMed ID: 23506206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's knowledge about cervical cancer, Pap smear and human papillomavirus and its relation to screening in Argentina.
    Paolino M; Arrossi S
    Women Health; 2011 Jan; 51(1):72-87. PubMed ID: 21391162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.